Top Markets
#1 Wrapped STX (Velar) Wrapped STX (Velar) +46.70%
#2 Pons Pons +35.30%
#3 TENDIES TENDIES +30.77%
#4 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +28.97%
#5 Starpower Starpower +28.18%
#6 StonkBroker StonkBroker +24.66%
#7 SkyAI SkyAI +24.29%
#8 Mubarak Mubarak +21.63%
#9 Decred Decred +19.96%
#10 PondCoin PondCoin +19.72%
Coin of the day
Wrapped STX (Velar) Wrapped STX (Velar)
Settings
Language
ENGLISH
Currency
USD
Theme
NexgenRx Inc. NexgenRx Inc.

NexgenRx Inc.

NEGXF
Rank in Stocks #29069
NexgenRx Inc., established in 2003 and based in Toronto, Canada, functions as a... NexgenRx Inc., established in 2003 and based in Toronto, Canada, functions as a third-party administrator for health benefit plans. The company's primary role involves efficiently managing, adjudicating, and processing payments for prescription drug, dental, and various other extended healthcare claims for individuals covered by plans offered by its clients across Canada. Beyond core claims handling, NexgenRx offers Health Care Spending Accounts (HCSAs), providing individuals with dedicated funds for their health or dental expenses. Its service portfolio also encompasses individual and aggregate stop-loss insurance products, emergency medical and travel assistance insurance, and a suite of administrative support functions. These administrative services include the collection and disbursement of premiums for life and long-term disability (LTD) coverage, complemented by advanced reporting tools. To enhance convenience, the company facilitates online claims submission and direct deposit services, along with other specialized ancillary services.
Share Price
$0.325
Last synced: 2026-08-18
Market Cap
$23.11M
Change (1 day)
0.00%
Change (1 year)
62.50%
Country
CA
Trade NexgenRx Inc. (NEGXF)

Category

Healthcare
P/E ratio for NexgenRx Inc. (NEGXF)
P/E ratio as of 2026 TTM: 0
According to NexgenRx Inc. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for NexgenRx Inc. from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
UnitedHealth Group Incorporated UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
UNH.US
 25.83 -
US
CVS Health Corp. CVS Health Corp.
CVS Health Corp.
CVS.US
 25.37 -
US
Elevance Health Inc. Elevance Health Inc.
Elevance Health Inc.
ELV.US
 17.79 -
US
Cigna Corporation Cigna Corporation
Cigna Corporation
CI.US
 11.65 -
US
Humana Inc. Humana Inc.
Humana Inc.
HUM.US
 36.53 -
US
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.